![Buckley Kohlhauff](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Buckley Kohlhauff
Directeur Technique/Scientifique/R&D chez
NURIX THERAPEUTICS, INC.
Profil
Buckley Kohlhauff is currently the Senior Vice President-Information Technology at Nurix Therapeutics, Inc. Prior to this, he held the position of Senior Director-Information Systems at Lexicon Pharmaceuticals, Inc. and Senior Director-Information Technology at Five Prime Therapeutics, Inc. He obtained his undergraduate degree from Carnegie Mellon University.
Postes actifs de Buckley Kohlhauff
| Sociétés | Poste | Début |
|---|---|---|
| NURIX THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/09/2021 |
Anciens postes connus de Buckley Kohlhauff
| Sociétés | Poste | Fin |
|---|---|---|
| LEXICON PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | - |
| FIVE PRIME THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Buckley Kohlhauff
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
2
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Carnegie Mellon University
 Carnegie Mellon University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lexicon Pharmaceuticals, Inc.
 Lexicon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Five Prime Therapeutics, Inc.
 Five Prime Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops protein therapeutics for cancer and inflammatory diseases | Health Technology |
Nurix Therapeutics, Inc.
 Nurix Therapeutics, Inc. BiotechnologyHealth Technology Operates as a a clinical stage biopharmaceutical company that discovers, develops and commercializes oral, small molecule therapies for the treatment of cancer & immune disorders | Health Technology |
